The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential
Pharmaceutics · 26.12.2024 · 17 (1) · 22
DOI: 10.3390/pharmaceutics17010022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 26.12.2024. Verfasst von Young-Shin Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Family Medicine Clinic and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangs…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pusan National University Yangsan Hospital.
Abstract (Originalsprache)
Lung cancer remains a major global health problem because of its high cancer-related mortality rate despite advances in therapeutic approaches. Non-small cell lung cancer (NSCLC), a major subtype of lung cancer, is more amenable to surgical intervention in its early stages. However, the prognosis for advanced NSCLC remains poor, owing to limited treatment options. This underscores the growing need for novel therapeutic strategies to complement existing treatments and improve patient outcomes. In recent years, pentacyclic triterpenoids, a group of natural compounds, have emerged as promising candidates for cancer therapy due to their anticancer properties. Pentacyclic triterpenoids, such as lupeol, betulinic acid, betulin, oleanolic acid, ursolic acid, glycyrrhetinic acid, glycyrrhizin, and asiatic acid, have demonstrated the ability to inhibit cell proliferation and angiogenesis, induce apoptosis, suppress metastasis, and modulate inflammatory and immune pathways in NSCLC cell line models. These compounds exert their effects by modulating important signaling pathways such as NF-κB, PI3K/Akt, and MAPK. Furthermore, advances in drug delivery technologies such as nanocarriers and targeted delivery systems have improved the bioavailability and therapeutic efficacy of triterpenoids. However, despite promising preclinical data, rigorous clinical trials are needed to verify their safety and efficacy. This review explores the role of triterpenoids in NSCLC and therapeutic potential in preclinical models, focusing on their molecular mechanisms of action.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Family Medicine Clinic and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
- Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Division of Pulmonology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
- School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
- Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Pusan National University Hospital, Busan 49241, Republic of Korea.
ORCID-Profile: Young-Shin Lee, Ryuk Jun Kwon, Yun Seong Kim, Han-Sol Jeong, Taehwa Kim, Seong Hoon Yoon
Förderung
- Pusan National University Yangsan Hospital
Zitieren
APA
Lee, Y. S., Kwon, R. J., Lee, H. S., Chung, J. H., Kim, Y. S., Jeong, H. S., Park, S. J., Lee, S. Y., Kim, T., & Yoon, S. H. (2024). The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential. Pharmaceutics, 17(1), 22. https://doi.org/10.3390/pharmaceutics17010022
Vancouver
Lee YS, Kwon RJ, Lee HS, Chung JH, Kim YS, Jeong HS, et al. The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential. Pharmaceutics. 2024;17(1):22. doi:10.3390/pharmaceutics17010022
BibTeX
@article{Lee2024,
author = {Lee, Young-Shin and Kwon, Ryuk Jun and Lee, Hye Sun and Chung, Jae Heun and Kim, Yun Seong and Jeong, Han-Sol and Park, Su-Jung and Lee, Seung Yeon and Kim, Taehwa and Yoon, Seong Hoon},
title = {The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential},
journal = {Pharmaceutics},
year = {2024},
volume = {17},
number = {1},
pages = {22},
doi = {10.3390/pharmaceutics17010022}
}
EUVIMED